Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pirfenidone and nintedanib in fibrosing interstitial lung disease: A retrospective study based on a regional university hospital data registry and literature review.

International journal of clinical pharmacology and therapeutics·2026
Same author

Opioid analgesic use during pregnancy: a drug utilization cohort study in Catalonia.

Frontiers in pharmacology·2026
Same author

Healthcare professionals' perspectives on medicine prescribing, vaccination, and alternative therapies in pregnancy and breastfeeding: A qualitative study from Catalonia, Spain.

PloS one·2026
Same author

Outlook of Cell Gene Therapies Development and Approval from Quality and Regulatory Perspective.

Therapeutic innovation & regulatory science·2026
Same author

Availability of pharmacological treatments for multiple myeloma in Spain.

The European journal of health economics : HEPAC : health economics in prevention and care·2026
Same author

Hospital admissions for acute drug poisoning in adults and children: a 7-year retrospective analysis of hospital discharges at a tertiary center.

Frontiers in toxicology·2025

Related Experiment Video

Updated: Jun 6, 2026

Using Simulation Models to Train Clinicians in the Use of Point-of-Care Ultrasound
05:04

Using Simulation Models to Train Clinicians in the Use of Point-of-Care Ultrasound

Published on: August 9, 2024

Educational sessions in pharmacovigilance: What do the doctors think?

Antonio Vallano1, Consuelo Pedrós, Antonia Agustí

  • 1Clinical Pharmacology Service, Bellvitge Biomedical Research Institute (IDIBELL), Bellvitge University Hospital-ICS, Department of Pathology and Experimental Therapeutics, University of Barcelona, Feixa Llarga s/n, 08035 L'Hospitalet de Llobregat, Barcelona, Spain. avallano@bellvitgehospital.cat.

BMC Research Notes
|November 19, 2010
PubMed
Summary

Physicians find pharmacovigilance feedback sessions valuable, showing high interest and satisfaction. These educational activities are a useful addition to hospital pharmacovigilance efforts.

More Related Videos

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

Related Experiment Videos

Last Updated: Jun 6, 2026

Using Simulation Models to Train Clinicians in the Use of Point-of-Care Ultrasound
05:04

Using Simulation Models to Train Clinicians in the Use of Point-of-Care Ultrasound

Published on: August 9, 2024

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

Area of Science:

  • Pharmacovigilance and Drug Safety
  • Medical Education

Background:

  • Physician feedback on pharmacovigilance sessions was assessed.
  • Sessions reviewed hospital-identified adverse drug reactions and regulatory/literature updates.
  • Physician opinions on interest, satisfaction, and utility were surveyed.

Purpose of the Study:

  • To determine physicians' opinions on the value of pharmacovigilance feedback sessions.
  • To evaluate physician interest, satisfaction, and perceived utility of these educational interventions.

Main Methods:

  • A survey using a 0-10 Likert scale was administered to physicians attending feedback sessions.
  • 115 out of 159 physicians (72.3%) participated.
  • Data analyzed for interest, satisfaction, and utility scores.

Main Results:

  • Physicians reported high mean scores for interest (7.52), satisfaction (7.58), and utility (8.05).
  • Significant differences in opinions were noted across medical categories and specialties.
  • The majority of participants (72.3%) completed the survey.

Conclusions:

  • Pharmacovigilance feedback sessions are a valuable educational tool for physicians.
  • Physicians express strong interest, satisfaction, and belief in the utility of these sessions.
  • Further research into developing and assessing pharmacovigilance educational activities is warranted.